Biogen to buy Massachusetts-based Alcyone Therapeutics (BIIB:NASDAQ)

Group 1 - Biogen has agreed to acquire Alcyone Therapeutics for an upfront payment of $85 million [5] - The acquisition includes additional milestone payments linked to the development and regulatory approval of ThecaFlex DRx [5]